Drugs to Treat Children With Immune Thrombocytopenia

Details

Files

Project Status:

Open for Stakeholder Feedback

Project Line:

Health Technology Review

Project Sub Line:

Technology Review

Project Number:

HC0033-000

Effective finish date:

May 31, 2024

Immune thrombocytopenia is a disorder characterized by low platelets and an increase in bleeding risk due to increased platelet destruction and impaired platelet production.

This project will review the clinical effectiveness and place in therapy of available treatments for children with immune thrombocytopenia who have not responded to first-line therapies.

Call for feedback

Call for feedback: Apr 18, 2024

Feedback Due By

Feedback Due By: May 3, 2024

Consultation document

Consultation document: Draft Report

Product Line

Product Line: Health Technology Review

Project Number

Project Number: HC0033-000

Submit Feedback